Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 1951-2000 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07217522
Rutgers University Study of the Genetics of Pulmonary Hypertension
N/ARecruiting
10,000 participants
Started: Aug 23, 2025 · Completed: Dec 31, 2027
8 conditions1 sponsor1 location
NCT07128030
Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study
PHASE1/PHASE2Recruiting
10 participants
Started: Aug 23, 2025 · Completed: Feb 23, 2026
3 conditions2 sponsors1 location
NCT07151040
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
PHASE1/PHASE2Recruiting
43 participants
Started: Aug 22, 2025 · Completed: Dec 31, 2026
6 conditions1 sponsor4 locations
NCT07178886
Breast Reconstruction and Radiotherapy
N/ARecruiting
750 participants
Started: Aug 22, 2025 · Completed: Dec 31, 2032
1 condition3 sponsors1 location
NCT07101874
A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients
N/ARecruiting
1,000 participants
Started: Aug 22, 2025 · Completed: Feb 28, 2026
1 condition2 sponsors28 locations
NCT07122076
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
EARLY_PHASE1Recruiting
10 participants
Started: Aug 22, 2025 · Completed: Aug 21, 2028
1 condition1 sponsor1 location
NCT07182474
Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE)
N/ARecruiting
120 participants
Started: Aug 22, 2025 · Completed: Oct 30, 2026
3 conditions1 sponsor1 location
NCT07182513
Turkish Version of the Hammersmith Neonatal Neurological Examination (HNNE)
N/ARecruiting
120 participants
Started: Aug 22, 2025 · Completed: Mar 15, 2026
4 conditions2 sponsors1 location
NCT06947304
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
PHASE1Recruiting
8 participants
Started: Aug 22, 2025 · Completed: Mar 31, 2026
4 conditions2 sponsors1 location
NCT07099274
Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy for Unresectable Intermediate-to-Advanced Hepatocellular Carcinoma
PHASE2Recruiting
29 participants
Started: Aug 22, 2025 · Completed: Dec 30, 2029
1 condition1 sponsor1 location
NCT07136012
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
PHASE3Recruiting
11,000 participants
Started: Aug 22, 2025 · Completed: Oct 20, 2031
1 condition1 sponsor138 locations
NCT07207291
Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers
PHASE1Recruiting
66 participants
Started: Aug 22, 2025 · Completed: Mar 19, 2026
4 conditions1 sponsor1 location
NCT07144800
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
N/ARecruiting
1,314 participants
Started: Aug 22, 2025 · Completed: Aug 22, 2029
3 conditions1 sponsor1 location
NCT07025785
Molecular Residual Disease Assessment in a Diverse Population of Patients With Early-stage Breast Cancer
N/ARecruiting
100 participants
Started: Aug 22, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors1 location
NCT06686446
Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial
NARecruiting
194 participants
Started: Aug 22, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT07145151
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
PHASE2Recruiting
156 participants
Started: Aug 22, 2025 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06682429
Telerehabilitation In The Home After Stroke
NARecruiting
202 participants
Started: Aug 22, 2025 · Completed: Jun 30, 2030
1 condition3 sponsors10 locations
NCT05618925
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
PHASE1Recruiting
20 participants
Started: Aug 22, 2025 · Completed: Mar 15, 2027
1 condition1 sponsor2 locations
NCT07120763
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
PHASE3Recruiting
50 participants
Started: Aug 22, 2025 · Completed: Aug 22, 2027
3 conditions1 sponsor1 location
NCT06822972
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
PHASE2Recruiting
27 participants
Started: Aug 22, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
PHASE1Recruiting
150 participants
Started: Aug 22, 2025 · Completed: Jun 30, 2032
7 conditions1 sponsor4 locations
NCT07085611
Neutralizing Power of Serum Antibodies - 2
NARecruiting
30 participants
Started: Aug 22, 2025 · Completed: Jul 11, 2035
6 conditions1 sponsor1 location
NCT06920004
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
PHASE3Recruiting
218 participants
Started: Aug 22, 2025 · Completed: Sep 30, 2030
3 conditions1 sponsor1 location
NCT06603818
Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)
PHASE2Recruiting
36 participants
Started: Aug 22, 2025 · Completed: Jun 1, 2027
3 conditions1 sponsor1 location
NCT07171255
Improving Exercise Adherence With App Technology for At-Risk Adults Living in Rural Kansas and Nebraska
NARecruiting
54 participants
Started: Aug 22, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT07201467
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
PHASE1/PHASE2Recruiting
12 participants
Started: Aug 22, 2025 · Completed: Dec 15, 2027
1 condition1 sponsor1 location
NCT06446245
Adjunctive Doxycycline for Central Nervous System Tuberculosis
PHASE2Recruiting
200 participants
Started: Aug 21, 2025 · Completed: Dec 31, 2027
4 conditions2 sponsors5 locations
NCT07082686
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
PHASE2Recruiting
68 participants
Started: Aug 21, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor29 locations
NCT06747611
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
PHASE2Recruiting
40 participants
Started: Aug 21, 2025 · Completed: Mar 15, 2028
3 conditions2 sponsors1 location
NCT07058077
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
PHASE2/PHASE3Recruiting
153 participants
Started: Aug 21, 2025 · Completed: Jan 24, 2037
1 condition1 sponsor2 locations
NCT06958328
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
PHASE3Recruiting
356 participants
Started: Aug 21, 2025 · Completed: Oct 21, 2030
4 conditions1 sponsor98 locations
NCT07191613
Effects of HAPPY GO GO Game on Health of Rural Elderly
NARecruiting
110 participants
Started: Aug 21, 2025 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT07018700
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
PHASE3Recruiting
990 participants
Started: Aug 21, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor28 locations
NCT07144111
A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib
PHASE1Recruiting
32 participants
Started: Aug 21, 2025 · Completed: Sep 6, 2026
1 condition1 sponsor4 locations
NCT06624475
Neoadjuvant Opdualag Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
PHASE2Recruiting
30 participants
Started: Aug 21, 2025 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT06993675
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
PHASE2Recruiting
50 participants
Started: Aug 21, 2025 · Completed: Aug 31, 2029
1 condition2 sponsors1 location
NCT07106294
Hyperspectral Imaging for Prediction of Preeclampsia
N/ARecruiting
1,430 participants
Started: Aug 21, 2025 · Completed: Jul 1, 2027
2 conditions1 sponsor1 location
NCT07147218
Accelerated TMS for MDD
NARecruiting
50 participants
Started: Aug 21, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06959524
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NARecruiting
1,616 participants
Started: Aug 21, 2025 · Completed: Mar 31, 2032
2 conditions1 sponsor1 location
NCT07154706
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
PHASE3Recruiting
180 participants
Started: Aug 21, 2025 · Completed: Aug 30, 2033
1 condition1 sponsor3 locations
NCT07218484
VoiceLove Digital Therapy for Delirium in the ICU
NARecruiting
15 participants
Started: Aug 21, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT07219693
QuantaFlo HD Clinical Validation Study
N/ARecruiting
600 participants
Started: Aug 21, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07100938
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
PHASE2Recruiting
90 participants
Started: Aug 21, 2025 · Completed: Oct 18, 2026
1 condition1 sponsor29 locations
NCT06980649
Study of BHV-1300 in Graves' Disease
PHASE1Recruiting
15 participants
Started: Aug 21, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor12 locations
NCT07055399
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)
PHASE2Recruiting
43 participants
Started: Aug 21, 2025 · Completed: Sep 1, 2029
1 condition4 sponsors1 location
NCT07180901
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NARecruiting
85 participants
Started: Aug 21, 2025 · Completed: Oct 21, 2029
3 conditions1 sponsor1 location
NCT07018713
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
PHASE3Recruiting
780 participants
Started: Aug 21, 2025 · Completed: Mar 31, 2028
1 condition1 sponsor30 locations
NCT07148414
A Study of SPY072 in Rheumatic Disease
PHASE2Recruiting
285 participants
Started: Aug 21, 2025 · Completed: Mar 31, 2028
8 conditions1 sponsor10 locations
NCT07088406
A Multi-level Mother-daughter Physical Activity Intervention for Pre- Adolescent Latinas
NARecruiting
432 participants
Started: Aug 21, 2025 · Completed: Aug 31, 2029
3 conditions2 sponsors1 location
NCT06958107
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
N/ARecruiting
300 participants
Started: Aug 21, 2025 · Completed: Jan 31, 2030
1 condition2 sponsors2 locations